Farizon, Mathilde
dos Santos, Sandra
Richard, Lucas
Petiteau, Agnès
Valentin, Anne-Sophie
van der Mee-Marquet, Nathalie
Alexandre, Kimberley
Allaire, Alexandra
Amandier, Karine
Audrain, Nathalie
Azzam, Amina
Bastard, Mehdi
Berrahal, Mélika
Berrouane, Yasmina
Betti, Marie-Camille
Bianchi, Claire
Blanié, Mathilde
Borrelys, Laetitia
Boschet, Caroline
Bourdet, Alexandre
Brisson, Jihane
Brechat, Anne
Buiguez, Dominique
Caffort, Sandra
Chatelet, Céline
Chatin, Catherine
Chevalier, Karine
Choquet, Armelle
Coire, Amélie
Courcelle, Karine
Cremoux, Nathalie
Dangel, Michèle
Debarre, Cécile
Decruyenaere, Lydia
Delavault, Peggy
Diaw, Frédérique
Dobras, Marie
Domrault-Tanguy, Carole
Drot, Sylvie
Duchemin, Audrey
Durand-Joly, Isabelle
El Kallas, Claude
Formery, Christelle
Fournier, Pierre
Franck, Aline
Ghalloussi, Blanche
Ghironi, Nathalie
Godet, Marie
Goudouneche, Anne
Gregoire, Jill
Guermazi, Hedia
Idri, Nadia
Jacques–Gustave, Emmanuelle
Joron, Sylvie
Joseph, Laurence
Kayoulou-Bour, Anne-Marie
Keswani, Maha
Kmiecik, Annick
Lafargue, Marie
Laffon, Magalie
Lafond, Elodie
Le Falher, Bruno
Le Gouil, Cécile
Leconte, Sophie
Malfondet, Florence
Marty, Sandrine
Mertel, Nadine
Morange, Virginie
Morette, Floriane
Mouronval, Jennifer
Moutarde, Sylvie
Negrin, Nadine
Ollivier, Dominique
Perez, Anne
Pommier, Pauline
Pouponnot, Kahina
Pouy Berlemont, Isabelle
Raumel, Samantha
Rossi, Patricia
Roudaut, Noella
Roux-Sibillon, Bénédicte
Saez de Ibarra, Dominique
Schrevens, Muriel
Sidikou, Ousseini
Tamburro, Bertille
Theaude, Catherine
Thevenot, Sarah
Turpin, Jessica
Valsaque, Morgane
Veja, Séverine
Wojciechowski, Lucie
Zangoli, Laure
,
Article History
Received: 18 May 2023
Accepted: 26 September 2023
First Online: 6 October 2023
Declarations
:
: All experiments were performed in accordance with relevant guidelines and regulations<b>.</b> The study was conducted within the framework of the national agency Santé Publique France and the national program for the prevention of healthcare-associated infections (National Health Strategy 2018–2022), which advocates for regular evaluation of healthcare professionals’ practices by local infection control teams. All work related to this program has been authorized by the CNIL (National Commission on Informatics and Liberties; file 2212596 dated March 27, 2019).The protocol for the CleanHand4 study was approved on June 15, 2021 by an ethics committee/institutional review board during a meeting of the scientific council of Santé Publique France agency, responsible for overseeing the implementation of the SPIADI program. The implementation of the study was monitored by the scientific committee overseeing the SPIADI program (March 8, 2022).Locally, participation in the study required written commitment from the hospital director and the infection control team leader. The commiment charters were collected at the national level by the SPIADI team. In the departments where the study was conducted, the observed professionals were informed about the study (observational component, microbiological component, and impact study of the proposed training). Informed consent was obtained from all observed professionals and all subjects for whom the placement of a CVP was observed and/or their legal guardian(s).
: Not applicable.
: The authors declare no competing interests.